Need of Epigenetic Biomarkers
The epigenome describes to the complete description of all potentially heritable modifications of the genome without any changes in primary DNA sequences. Epigenetic biomarkers can be widely defined as measurable modifications of the genome with preserved DNA sequence.
Epigenetic manupulation and regulators represent potential molecular elements which control relevant physiological and pathological features, thereby contributing to the natural history of human disease. These epigenetic modulators can be used as disease biomarkers, since they show several advantages and provide information about gene function, thus explaining differences among patient endophenotypes.
Noninvasive Epigenetic Markers can be used as biomarkers for the molecular diagnosis of following cancer:
- Prostate Cancer
- Bladder Cancer
- Colorectal Cancer
- Lung Cancer
- Breast Cancer
- Ovarian Cancer
Related Conference of Need of Epigenetic Biomarkers
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
Need of Epigenetic Biomarkers Conference Speakers
Recommended Sessions
- Biochemical approaches of Epigenetics
- Bioinformatics/ Computational Analysis of Epigenetics
- Brain disorders & Epigenetics
- Cancer Epigenetics & Oncology
- Chromatin & its Dynamics
- Cyto-epigenetic approaches
- Environmental Epigenetic Factor
- Epigenetics
- Epigenetics in Biotechnology & Developmental Biology
- Epigenetics in Cardiovascular Disease
- Epigenetics in Clinical Practice
- Epigenetics in Nervous System
- Epigenetics in Pharmacology & Drug Discovery
- Epigenetics in reproductive health
- Epigenetics Market Products & Instrumentation
- Genetics & Epigenetic inheritance
- Genomics and Epigenetics Division
- Immunology in the epigenetic era
- Medical Epigenetics
- Microbial Epigenetics
- Need of Epigenetic Biomarkers
- Plant Epigenetics
- Toxicoepigenetics
Related Journals
Are you interested in
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)